ASX Share rice
Tue 04 Aug 2020 - 03:07:am (Sydney)

CAN Share Price

CANN GROUP LIMITEDCANPharmaceuticals, Biotechnology & Life Sciences

CAN Company Information

Name:

Cann Group Limited

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

Walter and Eliza Hall Institute of Medical Research Bundoora VIC Australia 3083

Phone:

61 3 9095 7088

Chief Exec. Officer:

Mr. Peter Crock MBA

Gen. Mang. of Operations:

Mr. Neil Gripper

Head of Legal:

Mr. Steven Notaro

Gen. Mang. of Commercial:

Mr. Shane Duncan

Acting Chief Financial Officer:

Ms. Reena Dahiya

Company Overview:

Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution/supply of medicinal cannabis for a range of diseases and medical conditions in Australia. The company was founded in 2014 and is based in Bundoora, Australia.

CAN Share Price Information

Shares Issued:

193.03M

Market Capitalisation:

$87.83M

Revenue (TTM):

$3.08M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$-0.078

Operating Margin (TTM):

$-4.92

Return On Assets (TTM):

$-0.12

Return On Equity (TTM):

$-0.19

Quarterly Revenue Growth (YOY):

4.969

Gross Profit(TTM):

$2.14M

Diluted Earnings Per Share (TTM):

$-0.103

CAN CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$3.50M

Change To Liabilities:

$3.75M

Total Cashflow From Investing Activities:

$3.50M

Net Income:

$-10,926,317

Total Cash From Operating Activities:

$-7,422,547

Depreciation:

$1.56M

Other Cashflow From Investing Activities:

$-53,256

Change To Inventory:

$-1,478,037

Change To Account Receivables:

$-1,115,436

Capital Expenditures:

$25.33M

CAN Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-10,926,317

Net Income:

$-10,926,317

Gross Profit:

$1.88M

Operating Income:

$-12,632,383

Interest Expense:

$198.91K

Total Revenue:

$2.35M

Total Operating Expenses:

$14.51M

Cost Of Revenue:

$465.92K

CAN Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$112.59K

Total Liabilities:

$4.82M

Total Stockholder Equity:

$77.30M

Total Assets:

$82.11M

Common Stock:

$96.50M

Other Current Assets:

$391.14K

Retained Earnings:

$-21,179,118

Other Assets:

$85K

Cash:

$46.39M

Total Current Liabilities:

$4.82M

Property - Plant & Equipment:

$29.01M

Net Tangible Assets:

$77.19M

Long-Term Investments:

$1.29M

Total Current Assets:

$51.71M

Net Receivables:

$1.12M

Short-Term Investments:

$30.41M

Inventory:

$3.09M

Accounts Payable:

$4.82M

Non Currrent Assets (Other):

$85K

Short-Term Investments:

$30.41

Non Current Liabilities Total:

$0

CAN Share Price History

CAN News

07 Jul, 2020
Cann Group Limited (ASX:CAN) shareholders might be concerned after seeing the share price drop 15% in the last month...
20 Mar, 2020
Cann Group Limited's (ASX:CAN): Cann Group Limited engages in research and development, cultivation and production...
06 Feb, 2020
Aurora Cannabis Announces Appointment of Two New Independent Directors
EDMONTON , Feb. 6, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this afternoon. The Company also announced a business transformation plan that better aligns selling, general & administrative expenses, and capital expenditures with current market conditions.
03 Feb, 2020
Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility
23 Dec, 2019
EDMONTON , Dec. 23, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided an update on the readiness of its operations with the introduction of new product formats, recent industry recognitions and updates to existing operations. As a global leader in cannabis revenues, cannabis production, research, innovation and international market development, the Company intends to provide regular updates to its stakeholders in an effort to demonstrate continued transparency and disclosure.
21 Dec, 2019
EDMONTON , Dec. 21, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, announces a change to the Executive Team. Cam Battley has stepped down as Chief Corporate Officer effective December 20, 2019 . Mr. Battley joined Aurora in 2016, serving a number of senior roles critical to the success of the company in its early years before being named Chief Corporate Officer in 2018.
02 Dec, 2019
EDMONTON , Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, is pleased to acknowledge the Company's ranking in the 2019 annual Report on Business ("ROB") review of Corporate Boards, known as Board Games. Published in its 18th year, the ROB Board Games considers dozens of governance criteria, extending beyond those required by formal regulations.
EDMONTON , Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that one of the Company's oil products has now been approved for use under Ireland's new Medical Cannabis Access Programme (MCAP). Aurora's High CBD Oil Drops received approval from the Irish authorities and have now been added to a regulatory schedule by the Irish Minister of Health enabling importation, prescribing and supply under the scheme and is to date, one of only two products to gain such authorization.
27 Nov, 2019
Full Year 2019 Cann Group Ltd Earnings Call
EDMONTON , Nov. 27, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced the grand opening of its flagship retail store at 10:00 a.m. MT on November 27 th in the West Edmonton Mall, North America's largest mall. At approximately 11,000 square feet, Aurora has combined both a retail cannabis store and an immersive experiential space, encouraging visitors from around the world to explore unique products and participate in a rotating calendar of programming and events. Aurora's flagship store offers visitors a safe, age-gated retail experience in full compliance with all relevant federal and provincial regulations.
25 Nov, 2019
Aurora Cannabis Announces Pricing of Early Amended Conversion Privilege for Convertible Debentures
20 Nov, 2019
View from the C-Suite: Glen Ibbott, Chief Financial Officer, Aurora Cannabis Inc., tells his company's story. Filmed on October 16, 2019
Aurora Cannabis Strengthens Leadership Team Adding Chief Product Officer and Chief Integration Officer
19 Nov, 2019
EDMONTON , Nov. 19, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that the Company has received notice from holders of the Company's CAD $230 million 5% unsecured, convertible debentures due March 9, 2020 (the "Debentures"), representing approximately CAD $216 million principal amount, or approximately 94%, of the Debentures, voluntarily electing to convert their Debentures pursuant to the alternate settlement procedures as outlined in the indenture dated March 9, 2018 , as supplemented by the first supplemental indenture dated November 14, 2019 , between the Company and Computershare Trust Company of Canada (the "Supplemented Indenture"). The Company will issue a press release on November 22, 2019 after the close of trading of the stock exchanges, confirming the Amended Early Conversion Price (as defined in the Supplemented Indenture) and the Amended Early Conversion Ratio (as defined in the Supplemented Indenture).
14 Nov, 2019
TORONTO , Nov. 14, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that it has provided notice to all holders (the "Debentureholders") of the Company's CAD$230 million 5% unsecured, convertible debentures due March 9, 2020 (the "Debentures") of an opportunity to voluntarily convert their Debentures at the Amended Early Conversion Ratio (as defined herein). All Debentureholders will be able to convert their Debentures at the Amended Early Conversion Ratio during the period commencing on November 18, 2019 and ending at 5:00 p.m. ( Toronto time) on November 20, 2019 (the "Early Conversion Period").
Aurora Cannabis Announces First Quarter 2020 Results & Corporate Action Plan
11 Nov, 2019
Aurora Cannabis Announces 2019 AGM Voting Results
06 Nov, 2019
Aurora Cannabis to Host First Quarter 2020 Investor Conference Call
30 Oct, 2019
Aurora Cannabis Launches National Safety Campaign on Edibles